Expanding Horizons: Profusa Partners with AZ Sint Blasius Hospital

Profusa Expands Its Customer Network

Profusa, Inc. is thrilled to announce a significant addition to its growing network in Europe by partnering with the Department of Vascular Surgery at AZ Sint Blasius Hospital in Belgium. This collaboration is spearheaded by the highly esteemed vascular surgeon, Dr. Koen Deloose, who specializes in critical limb ischemia (CLTI) and has an impressive record of treating over 300 patients each year.

Dr. Koen Deloose: A Leader in Vascular Surgery

Dr. Deloose's expertise is widely recognized in the field of vascular surgery, as he not only treats patients but also engages in leadership roles within various clinical research organizations and at key European medical conferences. His commitment to delivering the best patient care is reflected in his approach, emphasizing innovative treatments and personalized care.

Innovation in Patient Monitoring

In discussing the collaboration, Dr. Deloose highlighted his experience with Profusa’s groundbreaking Lumee™ Oxygen measurement technology, which enhances the monitoring of endovascular procedures. This device provides vital real-time metrics on tissue oxygen perfusion, crucial for the successful management of patients undergoing treatment for CLTI. Dr. Deloose emphasizes that understanding the dynamics of oxygen at specific anatomical targets can significantly influence treatment outcomes.

A Multidisciplinary Approach for Better Patient Care

Recently, Dr. Deloose opened a new vascular clinic that adopts a multidisciplinary framework, incorporating specialists such as diabetic foot care experts and wound care professionals. This facility aims to offer patients state-of-the-art treatments and a comprehensive approach to vascular health. Dr. Deloose is also the chief medical officer of Kando Research, where he is dedicated to promoting advancements in vascular medicine and making innovative technologies readily available to patients.

Profusa's Commitment to Innovation and Patient Care

Ben Hwang, Chairman and CEO of Profusa, expressed enthusiasm about welcoming Dr. Deloose into their community of customers. He emphasized how this partnership aligns with Profusa's mission to make vital biochemical data accessible for improving health and wellness. The innovative Lumee Oxygen monitoring system is expected to play a significant role in Dr. Deloose’s clinical agenda, providing enhanced insights for managing CLTI patients.

About Profusa

Headquartered in Berkeley, California, Profusa, Inc. is a pioneering digital health company focused on developing next-generation tissue-integrated sensors that continuously generate actionable, medical-grade data. With its innovative and long-lasting biosensors, Profusa aims to provide individuals with reliable biochemical signatures that can inform personal and clinical decisions.

Frequently Asked Questions

What is the focus of Profusa, Inc.?

Profusa specializes in digital health technology, developing tissue-integrated sensors to monitor biochemistry continuously.

Who is Dr. Koen Deloose?

Dr. Deloose is a renowned vascular surgeon with expertise in treating critical limb ischemia and leads the vascular department at AZ Sint Blasius Hospital.

What technology does Profusa offer for monitoring?

Profusa offers the Lumee™ Oxygen measurement system, which provides real-time tissue oxygen perfusion metrics important for vascular treatments.

How does the new clinic led by Dr. Deloose enhance patient care?

The clinic adopts a multidisciplinary approach, incorporating various specialists to offer comprehensive care for vascular health.

What is Profusa's mission?

Profusa aims to improve health and wellness by making the body's biochemical data easily accessible for both patients and healthcare providers.

About The Author

My name is Dylan Bailey, and I am 28 years old. I am an author and an expert on the stock market who specializes in publicly traded companies. Early fascination with the stock market inspired me to seek a finance degree and then delve deeply into the world of stocks. I have developed over the years my abilities to spot investment prospects, assess business performance, and analyze market trends.

My books and articles try to help regular investors understand the nuances of the stock market. Anyone can, in my opinion, make wise investment choices and succeed financially if they have the correct information and resources. In my writing, I combine in-depth research with practical insights and advice that can be put into action. This is done with the intention of assisting readers in navigating the constantly shifting landscape of publicly traded companies.

In addition to writing, I also host webinars and workshops, where I give presentations and share my knowledge with a wider audience. I also write for top financial journals and show up as a guest analyst on financial news shows. I like to travel, spend time with my family, and keep active by playing different sports when I'm not buried in market research.

My goal is to enable people to choose wisely and consciously in their investments, so taking charge of their financial futures. By my work, I hope to create a community of informed and self-assured investors prepared to take advantage of the chances presented by the stock market.

Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.